# Spectrumedics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/spectrumedics

- Industry: Medical Devices & Equipment
- Headquarters: Shanghai, China
- Website: www.spectrumedics.com
- Total disclosed funding: $15M
- Latest round: Series B (Aug 17, 2024)
- Investors on record: 8

## About

Founded in 2019 and based in Shanghai, China, Spectrumedics operates as a therapeutic device developer dedicated to providing minimally invasive cardiac and vascular interventional therapy solutions. It has R&D Centres in Shanghai and Singapore. The founder of the company, Huiqun Peng graduated from Nanyang Technological University. The co-founder of the company, Al Ray Tabiliran has worked in Creganna-Tactx Medical and TriReme Medical, Inc. In August 2024, the company closed a round of series B funding.

The company mainly provides active cardiac and vascular intervention solutions. It provides coronary calcification solutions and peripheral calcification solutions. The coronary calcification solution is Sonico-CX® Shock Wave Balloon, which used for pretreatment and balloon dilatation of calcified lesions in coronary arteries in adult patients. The peripheral calcification solution is Sonico-PX® Shock Wave Balloon, which used for pretreatment and balloon dilatation of calcified lesions in peripheral arteries of adult patients. Spectrumedics also provides intravascular shock wave therapy equipment.

The company generates revenue by providing Sonico-CX® Shock Wave Balloon, Sonico-PX® Shock Wave Balloon, and intravascular shock wave therapy equipment.

## Funding rounds

- Series B, Aug 17, 2024 — Peakview Capital, Jiangsu Yangtze River International Metallurgical Industrial Park, Jiahong Medical
- Series A, May 7, 2022, $15M — Legend Capital, Sunmed Capital, BC Capital, Wide Capital
- Angel, Apr 17, 2020 — Sunmed Capital, Zhuchi Yunding Capital

## Investors

- Sunmed Capital (https://capitalatlas.ai/funds/sunmed-capital) — Angel, Series A
- Zhuchi Yunding Capital (https://capitalatlas.ai/funds/zhuchi-yunding-capital) — Angel
- Legend Capital — Series A
- BC Capital — Series A
- Wide Capital — Series A
- Peakview Capital — Series B
- Jiangsu Yangtze River International Metallurgical Industrial Park — Series B
- Jiahong Medical — Series B